We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $1B Turnover 3.6%
1-Year Est. Return 50.12%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+50.12%
3 Year Est. Return
+144.24%
5 Year Est. Return
+295.18%
10 Year Est. Return
+883.61%
AUM
$813M
AUM Growth
+$17.8M
Cap. Flow
+$10.4M
Cap. Flow %
1.27%
Top 10 Hldgs %
33.87%
Holding
156
New
13
Increased
58
Reduced
56
Closed
19
Avg Time Held
3.7 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
NPK icon
National Presto Industries
NPK
+$18.9M
2
INTU icon
Intuit
INTU
+$13M
3
ACVA icon
ACV Auctions
ACVA
+$12.7M
4
APA icon
APA Corp
APA
+$11.3M
5
MTDR icon
Matador Resources
MTDR
+$11.2M

Top Sells

Rank Stock Value
1
PHIN icon
Phinia Inc
PHIN
+$16.2M
2
TPR icon
Tapestry
TPR
+$15.2M
3
DJCO icon
Daily Journal
DJCO
+$13M
4
PM icon
Philip Morris
PM
+$10.3M
5
TSM icon
TSMC
TSM
+$8.56M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.5%
2 Technology 17.95%
3 Financials 10.66%
4 Industrials 10.58%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UNH icon
126
UnitedHealth
UNH
$360B
$575K 0.07%
2,125
-117
-5% -$34.8K
2013 Q2
51 quarters
BX icon
127
Blackstone
BX
$85.1B
$537K 0.07%
4,667
– –
2019 Q3
26 quarters
GLUE icon
128
Monte Rosa Therapeutics
GLUE
$831M
$514K 0.06%
31,236
-31,984
-51% -$612K
2025 Q4
1 quarter
AMPH icon
129
Amphastar Pharmaceuticals
AMPH
$1.1B
$496K 0.06%
25,335
+10,174
+67% +$249K
2023 Q1
12 quarters
PRGS icon
130
Progress Software
PRGS
$1.67B
$426K 0.05%
16,597
+2,238
+16% +$85.5K
2023 Q1
12 quarters
GENI icon
131
Genius Sports
GENI
$1.7B
$401K 0.05%
90,412
+3,439
+4% +$24.5K
2022 Q4
13 quarters
SPY icon
132
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$394K 0.05%
606
-1,192
-66% -$810K
2025 Q2
3 quarters
SDY icon
133
State Street SPDR S&P Dividend ETF
SDY
$21.5B
$316K 0.04%
2,164
+421
+24% +$62.7K
2025 Q4
1 quarter
NOBL icon
134
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
$237K 0.03%
4,462
– –
2023 Q4
9 quarters
ATOM icon
135
Atomera
ATOM
$120M
$76.2K 0.01%
20,000
– –
2021 Q1
20 quarters
BEAT icon
136
Heartbeam
BEAT
$24.6M
$61K 0.01%
50,000
– –
2023 Q2
11 quarters
CUE icon
137
Cue Biopharma
CUE
$121M
$59.1K 0.01%
8,574
– –
2021 Q1
20 quarters
ACWI icon
138
iShares MSCI ACWI ETF
ACWI
$32.6B
– –
-16,180
Closed -$2.29M –
ADUS icon
139
Addus HomeCare
ADUS
$2.17B
– –
-5,623
Closed -$604K –
BRBR icon
140
BellRing Brands
BRBR
$1.1B
– –
-23,379
Closed -$625K –
CTLP icon
141
DELISTED
Cantaloupe
CTLP
– –
-24,860
Closed -$264K –
DRVN icon
142
Driven Brands
DRVN
$1.97B
– –
-146,201
Closed -$2.17M –
GTES icon
143
Gates Industrial Corp
GTES
$6.54B
– –
-51,984
Closed -$1.12M –
HMC icon
144
Honda
HMC
$44.5B
– –
-142,234
Closed -$4.19M –
HRB icon
145
H&R Block
HRB
$5.96B
– –
-17,526
Closed -$764K –
IWM icon
146
iShares Russell 2000 ETF
IWM
$76.2B
– –
-5,364
Closed -$1.32M –
NCNO icon
147
nCino
NCNO
$2.17B
– –
-65,965
Closed -$1.69M –
OSW icon
148
OneSpaWorld
OSW
$2.42B
– –
-58,171
Closed -$1.21M –
PI icon
149
Impinj
PI
$5.36B
– –
-3,873
Closed -$674K –
REVG icon
150
DELISTED
REV Group
REVG
– –
-47,204
Closed -$2.87M –

Similar funds

Advisory Research's Q1 2026 Portfolio in Review

As of Q1 2026, Advisory Research held 156 positions worth $813M, up 2.2% from $796M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Advisory Research's Q1 2026 filing shows 13 new, 58 increased, 56 reduced and 19 closed positions. Its largest new stake was National Presto Industries: 147,634 shares worth $20.2M. The largest sale was Phinia Inc, an estimated $16.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

  • Advisory Research's largest Q1 2026 buy was National Presto Industries: 147,634 shares worth $20.2M.
  • Advisory Research added most to ACV Auctions in Q1 2026, an estimated $12.7M increase.
  • Advisory Research's biggest Q1 2026 reduction was Phinia Inc, cutting an estimated $16.2M.
  • Advisory Research fully exited Unilever in Q1 2026, selling an estimated $6.32M.
  • Advisory Research's ten largest holdings make up 34% of its $813M portfolio in Q1 2026.
  • Advisory Research opened 13 new positions and closed 19 in Q1 2026.
  • Advisory Research's portfolio value rose 2.2% quarter-over-quarter to $813M.

Based on Advisory Research's 13F filing for Q1 2026, filed 14 May 2026.